115 related articles for article (PubMed ID: 1720756)
1. Qualitative and quantitative platelet defect with bleeding symptoms as presenting feature of non Hodgkin lymphomas.
Bertolino G; Noris P; Balduini CL
Haematologica; 1991; 76(3):243-4. PubMed ID: 1720756
[TBL] [Abstract][Full Text] [Related]
2. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of medium and highly malignant non-Hodgkin's lymphoma with combined chemotherapy using methotrexate, adriamycin, cyclophosphamide, vincristine, prednisone and bleomycin (protocol MACOP-B)].
Pittrová H; Koza V; Vozobulová V; Cetkovský P; Skopek P; Jungerová J; Cepelák V
Vnitr Lek; 1989 Dec; 35(12):1177-82. PubMed ID: 2483776
[TBL] [Abstract][Full Text] [Related]
4. CBVPM/AVBP versus HCOMLA chemotherapy in non-Hodgkin lymphoma patients.
Pawelski S; Konopka L; Pakulska J; Gutkowska J
Chemioterapia; 1987 Jun; 6(2 Suppl):716-9. PubMed ID: 2475265
[No Abstract] [Full Text] [Related]
5. Results of three polychemotherapy programs in non-Hodgkin's lymphomas.
Konopka L; Pawelski S
J Chemother; 1989 Jul; 1(4 Suppl):1259-62. PubMed ID: 16312857
[No Abstract] [Full Text] [Related]
6. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
[TBL] [Abstract][Full Text] [Related]
7. Stevens-Johnson syndrome associated with methotrexate treatment for non-Hodgkin's lymphoma.
Cuthbert RJ; Craig JI; Ludlam CA
Ulster Med J; 1993 Apr; 62(1):95-7. PubMed ID: 7685956
[No Abstract] [Full Text] [Related]
8. Malignant histiocytosis resistant to anthracycline. Response to intensive treatment with etoposide and amsacrine.
Abrams RA; Hanson G; Hansen R; Baumann MA; Anderson T
Arch Intern Med; 1985 Apr; 145(4):742-3. PubMed ID: 3872645
[TBL] [Abstract][Full Text] [Related]
9. Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
Miller TP; Dana BW; Weick JK; Jones SE; Coltman CA; Dahlberg S; Fisher RI
Semin Hematol; 1988 Apr; 25(2 Suppl 2):17-22. PubMed ID: 2456619
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation.
Schouten HC; Armitage JO; Klassen LW; Vaughan WP; Bierman PJ; Weisenburger D; Kessinger A
Bone Marrow Transplant; 1989 Jan; 4(1):119-21. PubMed ID: 2466510
[TBL] [Abstract][Full Text] [Related]
11. [Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives].
Bron D; Vandenheule B; Stryckmans P
Rev Med Brux; 1985 Sep; 6(7):491-5. PubMed ID: 2417298
[No Abstract] [Full Text] [Related]
12. Primary cardiac T-cell lymphoma.
Giunta R; Cravero RG; Granata G; Sellitto A; Romano C; De Fanis U; Foccillo G; De Capite C; Santini M; Rossiello L; Rossiello R; Lucivero G
Ann Hematol; 2004 Jul; 83(7):450-4. PubMed ID: 14722737
[TBL] [Abstract][Full Text] [Related]
13. [Thyroid lymphoma in a 51-year-old woman].
Herranz MT; Corrales A; Molina MA; Redondo E; Almagro M; Martí J
An Med Interna; 1993 Mar; 10(3):132-4. PubMed ID: 7683502
[TBL] [Abstract][Full Text] [Related]
14. Non-hodgkins lymphoma.
Mead G; Woodcock J; Young C
Clin Evid; 2003 Jun; (9):1-21. PubMed ID: 12967352
[No Abstract] [Full Text] [Related]
15. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
16. Hepatosplenic gammadelta T-cell lymphoma presenting with immune-mediated thrombocytopenia and hemolytic anemia (Evans' syndrome).
Motta G; Vianello F; Menin C; De Nicolo A; Agata S; Altavilla G; Pietrogrande F; Girolami A
Am J Hematol; 2002 Apr; 69(4):272-6. PubMed ID: 11921021
[TBL] [Abstract][Full Text] [Related]
17. [An apparently primary lymphoma of the testicle].
Belbusti F; Signoretti P; Tondi MR; Sparaventi G
G Chir; 1991; 12(8-9):438-40. PubMed ID: 1721520
[TBL] [Abstract][Full Text] [Related]
18. [Malignant lymphomas. Preliminary report of the National Protocol of Antineoplastic Drugs].
Gutiérrez J; Osorio G; García H; Vacarezza R; Cao C
Rev Med Chil; 1991 Sep; 119(9):990-1000. PubMed ID: 1726958
[TBL] [Abstract][Full Text] [Related]
19. Hematologic malignancies: non-Hodgkin's lymphomas.
DeVita VT
Hosp Pract (Off Ed); 1986 Sep; 21(9):103-18. PubMed ID: 2427535
[No Abstract] [Full Text] [Related]
20. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
